◆英語タイトル:Heron Therapeutics Inc (HRTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010939
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-based drug delivery platform, which improves the therapeutic profile of injectable pharmaceuticals. The company’s first commercial product Sustol is an extended-release injection indicated in combination with other antiemetics in adults for the prevention of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. Heron’s developmental pipeline includes HTX-011 for post-operative pain management and Cinvanti (HTX-019) for chemotherapy-induced nausea and vomiting (CINV) prevention. Heron is headquartered in San Diego, California, the US.
Heron Therapeutics Inc (HRTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Heron Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Heron Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Heron Therapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 10
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 12
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 14
Heron Therapeutics Inc – Key Competitors 15
Heron Therapeutics Inc – Key Employees 16
Heron Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 09, 2017: Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 18
May 10, 2017: Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 20
Feb 23, 2017: Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress 21
Nov 08, 2016: Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress 22
Aug 08, 2016: Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress 23
May 05, 2016: Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Progress 24
Feb 19, 2016: Heron Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results and Recent Corporate Progress 25
Corporate Communications 26
Apr 24, 2017: Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, Finance 26
Jun 22, 2016: Heron Therapeutics Announces Appointment of Christian Waage to Board of Directors 27
Mar 17, 2016: Heron Therapeutics Appoints David L. Szekeres, SVP Business Development, General Counsel and Corporate Secretary 28
Jan 28, 2016: Heron Therapeutics Appoints Kimberly J. Manhard as Executive Vice President of Drug Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Tables
Heron Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Heron Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Heron Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 10
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 12
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 14
Heron Therapeutics Inc, Key Competitors 15
Heron Therapeutics Inc, Key Employees 16
Heron Therapeutics Inc, Other Locations 17